Pharma — Januar 2022
-
Could AstraZeneca Help You Retire a
Millionaire? https://www.proinvestor.com/investornyt/757873/could-astrazeneca-help-you-retire-a-millionaire -
Bioporto på himmelfart efter forlænget undersøgelse af covid-19-test https://proinvestor.com/investornyt/758103/bioporto-pa-himmelfart-efter-forlaenget-undersogelse-af-covid-19-test
-
Novo og sundhedsaktier ramt af genåbningshåb vurderer strateg https://www.proinvestor.com/investornyt/758638/novo-og-sundhedsaktier-ramt-af-genabningshab-vurderer-strateg
-
Lundbeck får udvidet godkendelse af Rexulti i USA til brug i unge https://www.proinvestor.com/investornyt/760033/lundbeck-far-udvidet-godkendelse-af-rexulti-i-usa-til-brug-i-unge
-
3 Top Healthcare Stocks to Buy for January https://www.proinvestor.com/investornyt/761425/3-top-healthcare-stocks-to-buy-for-january
-
3 Big FDA Approvals to Watch For in Q1 2022 https://www.proinvestor.com/investornyt/761636/3-big-fda-approvals-to-watch-for-in-q1-2022
-
Here's A Better Pharmaceutical Pick Over Merck Stock https://www.proinvestor.com/investornyt/763435/heres-a-better-pharmaceutical-pick-over-merck-stock
-
Teva: Kåre Schultz giver klar melding på konference https://www.proinvestor.com/index.php?p=debat_1&postid=100114
-
Why This Under-the-Radar Healthcare Stock Could Be a Big Winner https://www.proinvestor.com/investornyt/765601/why-this-under-the-radar-healthcare-stock-could-be-a-big-winner
-
3 Pharma Stocks With Especially Juicy Dividends https://www.proinvestor.com/investornyt/765981/3-pharma-stocks-with-especially-juicy-dividends
-
Better Dividend Stock: AbbVie or Pfizer? https://www.proinvestor.com/investornyt/773458/better-dividend-stock-abbvie-or-pfizer
-
Roche: FDA Approves Vabysmo To Treat Two Vision-threatening Retinal Conditions https://www.proinvestor.com/investornyt/773501/roche-fda-approves-vabysmo-to-treat-two-vision-threatening-retinal-conditions
-
Sanofi: CHMP Recommends Approval Of Dupixent For Children With Severe Asthma With Type2 Inflammation https://www.proinvestor.com/investornyt/773492/sanofi-chmp-recommends-approval-of-dupixent-for-children-with-severe-asthma-with-type2-inflammation
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind